Onconetix (ONCO) Equity Average (2023 - 2025)
Historic Equity Average for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $4.6 million.
- Onconetix's Equity Average fell 2448.44% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 2448.44%. This contributed to the annual value of $5.0 million for FY2024, which is N/A changed from last year.
- Onconetix's Equity Average amounted to $4.6 million in Q3 2025, which was down 2448.44% from $5.0 million recorded in Q2 2025.
- Onconetix's 5-year Equity Average high stood at $24.8 million for Q4 2024, and its period low was -$21.6 million during Q2 2024.
- Over the past 3 years, Onconetix's median Equity Average value was $6.0 million (recorded in 2023), while the average stood at $5.2 million.
- Examining YoY changes over the last 5 years, Onconetix's Equity Average showed a top increase of 32578.47% in 2024 and a maximum decrease of 23191.13% in 2024.
- Onconetix's Equity Average (Quarter) stood at $5.8 million in 2023, then surged by 325.78% to $24.8 million in 2024, then tumbled by 81.27% to $4.6 million in 2025.
- Its Equity Average stands at $4.6 million for Q3 2025, versus $5.0 million for Q2 2025 and $6.3 million for Q1 2025.